Literature DB >> 12371000

Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease.

Timothy R Aksamit1.   

Abstract

Patients with MAC-PD and pre-existing lung disease are a distinct group from the more common and recently recognized group of predominantly middle- to older-aged women without pre-existing lung disease. Those with pre-existing disease are expected to have more sputum positivity and slower conversion of sputum with treatment, and they may require combined medical treatment with surgical resection for optimal results. Attention to bronchial hygiene, avoidance of unnecessary use of macrolides, and treatment of underlying esophageal and lung disease can result in marked symptomatic improvement in many cases. Appropriate consideration must be given to mycobacterial antibiotic treatment, and awareness must be maintained for other processes such as bronchogenic cancer in select groups of high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371000     DOI: 10.1016/s0272-5231(02)00022-9

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  24 in total

1.  Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns.

Authors:  Chin-Chung Shu; Chih-Hsin Lee; Chia-Lin Hsu; Jann-Tay Wang; Jann-Yuan Wang; Chong-Jen Yu; Li-Na Lee
Journal:  Lung       Date:  2011-09-29       Impact factor: 2.584

2.  Rapid identification of mycobacteria from smear-positive sputum samples by nested PCR-restriction fragment length polymorphism analysis.

Authors:  Tsu-Lan Wu; Ju-Hsin Chia; An-Jing Kuo; Lin-Hui Su; Ting-Shu Wu; Hsin-Chih Lai
Journal:  J Clin Microbiol       Date:  2008-09-03       Impact factor: 5.948

3.  Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice.

Authors:  Luiz E Bermudez; Clark B Inderlied; Peter Kolonoski; Christopher B Chee; Priscilla Aralar; Mary Petrofsky; Toufan Parman; Carol E Green; Anita H Lewin; William Y Ellis; Lowell S Young
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

4.  A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.

Authors:  George Carter; Lowell S Young; Luiz E Bermudez
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  Isolation of a novel strain of Mycobacterium iranicum from a woman in the United States.

Authors:  Nandhakumar Balakrishnan; Enrico Tortoli; Susan L Engel; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

6.  Nontuberculous mycobacterial infections among patients suspected of pulmonary tuberculosis.

Authors:  H Grubek-Jaworska; R Walkiewicz; A Safianowska; M Nowacka-Mazurek; R Krenke; T Przybyłowski; R Chazan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-14       Impact factor: 3.267

7.  Virulence-related Mycobacterium avium subsp hominissuis MAV_2928 gene is associated with vacuole remodeling in macrophages.

Authors:  Samradhni S Jha; Lia Danelishvili; Dirk Wagner; Jörg Maser; Yong-jun Li; Ivana Moric; Steven Vogt; Yoshitaka Yamazaki; Barry Lai; Luiz E Bermudez
Journal:  BMC Microbiol       Date:  2010-04-01       Impact factor: 3.605

8.  The impact of low subcutaneous fat in patients with nontuberculous mycobacterial lung disease.

Authors:  Seok Jeong Lee; Yon Ju Ryu; Jin Hwa Lee; Jung Hyun Chang; Sung Shine Shim
Journal:  Lung       Date:  2014-02-19       Impact factor: 2.584

9.  Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.

Authors:  Richard D Kim; David E Greenberg; Mary E Ehrmantraut; Shireen V Guide; Li Ding; Yvonne Shea; Margaret R Brown; Milica Chernick; Wendy K Steagall; Connie G Glasgow; JingPing Lin; Clara Jolley; Lynn Sorbara; Mark Raffeld; Suvimol Hill; Nilo Avila; Vandana Sachdev; Lisa A Barnhart; Victoria L Anderson; Reginald Claypool; Dianne M Hilligoss; Mary Garofalo; Alan Fitzgerald; Sandra Anaya-O'Brien; Dirk Darnell; Rosamma DeCastro; Heather M Menning; Stacy M Ricklefs; Stephen F Porcella; Kenneth N Olivier; Joel Moss; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

10.  Cloning and characterization of CYP51 from Mycobacterium avium.

Authors:  Michael P Pietila; Pawan K Vohra; Bharati Sanyal; Nancy L Wengenack; Sreekumar Raghavakaimal; Charles F Thomas
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-16       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.